Background {#section1-2151459320929581}
==========

Hip fractures are common orthopedic injuries that require substantial hospital resources, costing an estimated US\$9.2 billion dollars annually in the United States.^[@bibr1-2151459320929581]^ This figure is expected to grow, as the annual incidence of hip fractures in the United States is projected to exponentially increase over the next several years.^[@bibr2-2151459320929581]^ These anticipated trends are worrisome, as this injury possesses some of the poorest outcomes in orthopedic surgery. Currently, studies estimate that 2% to 14% of patients die during the same hospital admission and 14% to 36% die within a year of their index surgery.^[@bibr3-2151459320929581][@bibr4-2151459320929581][@bibr5-2151459320929581]-[@bibr6-2151459320929581]^ Of those that survive, 58% continue to have difficulty ambulating without an assistive device at 1 year after their surgery.^[@bibr7-2151459320929581]^ As a consequence, the high incidence of hip fractures, coupled with the high morbidity and mortality rates, has caused this condition to become a major public health concern. In an effort to mitigate rising costs and suboptimal outcomes, studies have investigated various elements of this injury.

Risk factors have been heavily scrutinized in an attempt to implement fracture prevention strategies. As such, studies have demonstrated poor nutritional status, tobacco use, low body mass index (BMI), and the presence of osteoporosis to significantly increase fracture risk.^[@bibr8-2151459320929581][@bibr9-2151459320929581][@bibr10-2151459320929581][@bibr11-2151459320929581]-[@bibr12-2151459320929581]^ Thus, providers have focused on modifiable risk factors, such as the treatment of osteoporosis and smoking cessation, as methods to reduce risk. Although helpful, these approaches have been met with limited success as the risk of fracture remains elevated despite intervention.^[@bibr13-2151459320929581],[@bibr14-2151459320929581]^ Studies have also reported on the importance of perioperative timing, such as the time-to-surgical-intervention and time-to-rehabilitation. If patients experience a delay in surgery beyond 48 hours, their risk of postoperative complications and death significantly increases.^[@bibr15-2151459320929581]^ Additionally, if patients delay postoperative ambulation past 48 hours, they experience lower survival rates, higher mortality rates, and higher postoperative complication rates.^[@bibr16-2151459320929581],[@bibr17-2151459320929581]^ Other studies have examined the institutional changes in how hospitals care for hip fracture patients. Hospitals are beginning to integrate medicine services to provide more global care, as many of these patients have preexisting conditions and functional deficits.^[@bibr18-2151459320929581]^ As a result, studies have found this approach to facilitate shorter length of stays and fewer negative outcomes.^[@bibr19-2151459320929581],[@bibr20-2151459320929581]^ The diversity of the aforementioned studies exemplifies the complex nature of hip fractures and illustrates the multifaceted care required to improve outcomes.

There have been a bevy of previous reports providing valuable information pertaining to hip fracture management. However, studies documenting recent national trends as a reflection of management changes have been sparse. Therefore, this study investigated the current trends in hip fractures throughout the United States. Specifically, this study utilized a large national database assessing (1) yearly incidences, (2) demographic factors, (3) post-fracture outcomes, (4) primary diagnoses, and (5) primary procedures for hip fracture patients between 2009 and 2016.

Materials and Methods {#section2-2151459320929581}
=====================

Database Selection {#section3-2151459320929581}
------------------

The utilized database, the National Inpatient Sample (NIS), is one of several publicly available databases collected by the Agency for Healthcare Research and Quality and distributed by the Health Care Utilization Project (HCUP). This database contains 20% of all inpatient hospital stays throughout the United States, representing over 7 million annual hospitalizations.^[@bibr21-2151459320929581]^ Once weighted, this database estimates more than 35 million hospitalizations. As a result of this database being deidentified, this study was exempt from institutional review board approval.

Patient Selection {#section4-2151459320929581}
-----------------

We queried the NIS for patients who were admitted with hip fractures from January 1, 2009, to December 31, 2016. Hip fracture patients were identified by *International Classification of Disease, Ninth and Tenth* Revisions (*ICD-9* and *ICD-10*) diagnosis codes. Patients included in this study possessed *ICD-9* or *ICD-10* codes involving fractures of the femoral head, neck, intertrochanteric, and subtrochanteric regions, yielding 2 761 850 patients. Exclusion criteria included patients sustaining isolated acetabular fractures, pelvic fractures, and femoral shaft fractures.

Study Variables {#section5-2151459320929581}
---------------

Patient demographics included age, sex, race, obesity status, Charlson Comorbidity Index (CCI) rank, smoking status, and osteoporosis status. Race was categorized into Caucasian, African American, Hispanic, Asian or Pacific Islander, Native American, or other. Patients were considered obese if they possessed the proper diagnosis codes pertaining to obesity status, while any entry without a code was considered nonobese. As the NIS does not provide BMI status, obese patients were obtained by querying the database with the respective *ICD-9* (278.00, 278.01) and *ICD-10* (E66.0, E66.01, E66.9) diagnosis codes. The CCI is a weighted index meant to predict risk of death within 1 year of hospitalization in patients with 19 specific comorbid conditions.^[@bibr22-2151459320929581]^ Each patient had their CCI calculated utilizing diagnosis codes within the NIS and were subsequently categorized into CCI scores of 0, 1, 2, or 3+.

Postoperative outcomes included lengths of stay (LOS), discharge dispositions, charges, costs, mortalities, and inpatient complications. Additionally, primary diagnoses, secondary diagnoses, and primary procedures were recorded. Discharge dispositions included home discharges, discharges to short-term hospitals (critical access hospitals, cancer centers, and federal health care facilities), discharges to other facilities (skilled nursing, intermediate care, inpatient rehabilitation, long-term care hospitals, and hospice), discharges home with home health care, and discharges against medical advice. Cost was defined as the dollar amount accrued by the hospital for the duration of the patient's hospital stay and were estimated using the supplemental "Cost-to-Charge Ratio" files provided by the HCUP. Charges were defined as the dollar amount billed by the hospital to the primary payer. The data regarding total charges is available within the NIS database, as it is a data element gathered by the HCUP. Obtained charges and costs were adjusted using the January 1, 2019, consumer price index. Inpatient complications included myocardial infarctions (MIs), cardiac arrests, deep vein thromboses (DVTs), pulmonary emboli (PEs), respiratory failures, pneumoniae, hematomas/seromas, mechanical complications, sepsis, urinary tract infections (UTIs), and blood transfusions. Mechanical complications consisted of any fracture, loosening, dislocation, or mechanical breakdown of implants.

Statistical Analysis {#section6-2151459320929581}
--------------------

Chi-squares were utilized for categorical variables, while student *t* tests and 1-way analyses of variance and were utilized for continuous variables. All data were examined using the 25th version of the SPSS (IBM Corporation). Statistical significance was set to a *P* value of less than .05.

Results {#section7-2151459320929581}
=======

Patient Demographic {#section8-2151459320929581}
-------------------

The gross number of hip fractures fluctuated over the study period, although an overall decrease was observed, with 339 786 patients having hip fractures in 2009 and 335 860 in 2016 (*P* \< .001; [Table 1](#table1-2151459320929581){ref-type="table"}). The mean age of patients decreased throughout the study (78-77 years), and the proportion of males significantly increased (+2.2%; *P* \< .001 for both). Caucasians were the most common race having hip fractures, consistently comprising greater than 85% of all hip fractures. Furthermore, there were increases in the proportion of African Americans (+0.7%) and Hispanics (+0.2%) and decreases in Native Americans (−0.2%) and other races (−0.5%; *P* \< .001). The proportion of obese patients significantly increased (+1.7%; *P* \< .001). The most common CCI, 3+, comprised over 90% of hip fracture patients and increased (+0.1%; *P* \< .001). Significantly more patients were smokers (+3.2%) and less patients had a diagnosis of osteoporosis (−4.0%; *P* \< .001 for both).

###### 

Demographics of Patients Sustaining Hip Fractures From 2009 to 2016.

![](10.1177_2151459320929581-table1)

  Parameter (%)                2009             2010             2011             2012             2013             2014             2015             2016             *P* value
  ---------------------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- -----------
  Incidence                    339 786          339 438          346 262          339 075          346 405          357 805          356 220          335 860          
  Mean age (years; SD)         78 (14.76)       77 (15.51)       78 (14.57)       77 (14.40)       77 (14.44)       77 (14.34)       77 (14.33)       77 (13.92)       \<.001
  Sex                                                                                                                                                                  \<.001
   Female                      234 440 (69.1)   231 573 (68.3)   238 584 (68.9)   232 930 (68.7)   236 970 (68.2)   242 235 (67.7)   239 785 (67.3)   224 640 (66.9)   
   Male                        104 962 (30.9)   107 629 (31.7)   107 532 (31.1)   106 135 (31.3)   110 400 (31.8)   115 525 (32.3)   116 395 (32.7)   111 120 (33.1)   
  Race                                                                                                                                                                 \<.001
   Caucasians                  247 315 (85.7)   259 166 (85.6)   270 957 (86.2)   272 970 (85.1)   280 135 (85.5)   289 545 (85.3)   287 370 (85.0)   275 735 (85.5)   
   African American            12 366 (4.3)     16 433 (5.4)     15 143 (4.8)     16 015 (5.0)     16 185 (4.9)     16 620 (4.9)     17 340 (5.1)     16 240 (5.0)     
   Hispanic                    15 297 (5.3)     15 149 (5.0)     16 997 (5.4)     16 950 (5.3)     17 645 (5.4)     19 105 (5.6)     18 910 (5.6)     17 745 (5.5)     
   Asian/Pacific Islander      4849 (1.7)       4554 (1.5)       4201 (1.3)       5490 (1.7)       5625 (1.7)       5815 (1.7)       6655 (2.0)       5550 (1.7)       
   Native American             1617 (0.6)       2115 (0.7)       1135 (0.4)       1750 (0.5)       1405 (0.4)       1450 (0.4)       1450 (0.4)       1145 (0.4)       
   Other                       7234 (2.5)       5515 (1.8)       5820 (1.9)       7715 (2.4)       6535 (2.0)       7095 (2.1)       6165 (1.8)       6245 (1.9)       
  Body mass index                                                                                                                                                      \<.001
   Nonobese                    329 710 (97.0)   328 507 (96.8)   333 662 (96.4)   325 520 (96.0)   332 935 (95.8)   341 395 (95.4)   339 080 (95.2)   319 985 (95.3)   
   Obese                       10 075 (3.0)     10 931 (3.2)     12 600 (3.6)     13 555 (4.0)     14 470 (4.2)     16 410 (4.6)     17 140 (4.8)     15 875 (4.7)     
  Charlson Comorbidity Index                                                                                        \<.001                                             
   0                           7849 (2.3)       9420 (2.8)       7123 (2.1)       7680 (2.3)       7655 (2.2)       8040 (2.2)       8430 (2.4)       8025 (2.4)       
   1                           5139 (1.5)       5809 (1.7)       4796 (1.4)       4950 (1.5)       4970 (1.4)       4610 (1.3)       4820 (1.4)       3825 (1.1)       
   2                           10 809 (3.2)     10 999 (3.2)     10 641 (3.1)     10 600 (3.2)     11 060 (3.2)     11 865 (3.3)     11 095 (3.1)     11 235 (3.3)     
   3+                          315 990 (93.0)   313 210 (92.3)   323 702 (93.5)   315 845 (93.1)   323 720 (93.2)   333 290 (93.1)   331 875 (93.2)   312 775 (93.1)   
  Smoking status                                                                                                                                                       \<.001
   Nonsmoker                   309 017 (90.9)   306 937 (90.4)   311 970 (90.1)   303 595 (89.5)   309 695 (89.1)   317 340 (88.7)   312 975 (87.9)   294 440 (87.7)   
   Smoker                      30 769 (9.1)     32 501 (9.6)     34 292 (9.9)     35 480 (10.5)    37 710 (10.9)    40 465 (11.3)    43 245 (12.1)    41 420 (12.3)    
  Osteoporosis                                                                                                                                                         \<.001
   No osteoporosis             270 114 (79.5)   270 978 (79.8)   275 717 (79.6)   273 155 (80.6)   282 170 (81.2)   290 855 (81.3)   290 885 (81.7)   280 610 (83.5)   
   Osteoporosis                69 672 (20.5)    68 461 (20.2)    70 545 (20.4)    65 920 (19.4)    65 235 (18.8)    66 950 (18.7)    65 335 (18.3)    55 250 (16.5)    

Postoperative Outcomes {#section9-2151459320929581}
----------------------

From 2009 to 2016, mean LOS decreased from 6.30 to 5.64 days (*P* \< .001). Charges increased by US\$17 984.93 (*P* \< .001) and costs increased by US\$1027.32 (*P* \< .001), while mortality decreased (−0.5%; *P* \< .001; [Table 2](#table2-2151459320929581){ref-type="table"}). Discharges to other facilities, the most common disposition, increased (+0.5%), as did home health care (+0.9%), while home discharges (−0.4%) and discharges to short-term hospitals (−0.6%) decreased (*P* \< .001). The overall complication rate significantly decreased by 12.8% (*P* \< .001; [Table 3](#table3-2151459320929581){ref-type="table"}). Complications that significantly decreased included MIs (−0.6%; *P* \< .001), DVTs (−0.l%; *P* \< .001), PEs (−0.1%; *P* \< .001), pneumonia (−1.1%; *P* \< .001), hematomas/seromas (−0.5%; *P* \< .001), UTIs (−3.1%; *P* \< .001), and transfusions (−16.3%; *P* \< .001). Complications that significantly increased included cardiac arrests (+0.2%; *P* \< .001), respiratory failures (+2.7%; *P* \< .001), mechanical complications (+0.2%; *P* \< .001), and sepsis (+0.8%; *P* \< .001).

###### 

Postoperative Outcomes in Hip Fracture Patients From 2009 to 2016.

![](10.1177_2151459320929581-table2)

  Parameter (%)                    2009                            2010                            2011                            2012                            2013                            2014                            2015                            2016                            *P*-value
  -------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- ------------------------------- -----------
  Mean length of stay (days; SD)   6.30 (6.41)                     6.29 (6.34)                     6.00 (5.44)                     6.00 (5.84)                     5.90 (5.81)                     5.87 (6.06)                     5.77 (5.46)                     5.64 (5.09)                     \<.001
  Charges (SD)                     US\$58 454.23 (US\$64 161.79)   US\$63 477.38 (US\$68 456.85)   US\$64 900.23 (US\$67 273.47)   US\$66 104.69 (US\$72 750.41)   US\$67 984.71 (US\$75 863.03)   US\$70 289.20 (US\$81 630.72)   US\$73 762.19 (US\$79 949.35)   US\$76 439.16 (US\$81 508.83)   \<.001
  Costs (SD)                       US\$17 990.46 (US\$16 308.21)   US\$18 790.08 (US\$17 801.13)   US\$18 647.92 (US\$17 402.20)   US\$18 893.55 (US\$19 196.38)   US\$18 629.94 (US\$18 920.07)   US\$18 615.03 (US\$19 586.39)   US\$18 914.24 (US\$17 997.36)   US\$19 017.78 (US\$17 798.06)   \<.001
  Discharge disposition                                                                                                                                                                                                                                            \<.001                          
   Home                            29 843 (8.8)                    30 158 (8.9)                    27 128 (7.9)                    28 820 (8.5)                    31 240 (9.0)                    31 735 (8.9)                    31 810 (8.9)                    28 265 (8.4)                    
   Short-term hospitals^a^         9662 (2.8)                      9794 (2.9)                      9457 (2.7)                      9035 (2.7)                      8680 (2.5)                      8835 (2.5)                      8295 (2.3)                      7495 (2.2)                      
   Other facilities^b^             258 776 (76.2)                  256 531 (75.6)                  265 729 (76.9)                  260 045 (76.7)                  264 640 (76.2)                  273 195 (76.4)                  270 830 (76.1)                  257 355 (76.7)                  
   Home health care                30 586 (9.0)                    32 361 (9.5)                    32 500 (9.4)                    31 090 (9.2)                    32 880 (9.5)                    33 600 (9.4)                    34 195 (9.6)                    33 185 (9.9)                    
   Left against medical advice     448 (0.1)                       409 (0.1)                       405 (0.1)                       465 (0.1)                       375 (0.1)                       550 (0.2)                       1750 (0.5)                      1120 (0.3)                      
  Mortality                                                                                                                                                                                                                                                                                        \<.001
   Alive                           329 769 (97.1)                  329 479 (97.1)                  335 361 (97.1)                  329 670 (97.3)                  337 975 (97.4)                  348 170 (97.4)                  346 895 (97.4)                  327 470 (97.6)                  
   Deceased                        9884 (2.9)                      9844 (2.9)                      9995 (2.9)                      9245 (2.7)                      9165 (2.6)                      9420 (2.6)                      9100 (2.6)                      8130 (2.4)                      

^a^ Short-term Hospitals include critical access hospitals, cancer centers, and federal health care facilities.

^b^ Other facilities include skilled nursing, intermediate care, inpatient rehabilitation, long-term care hospitals, and hospice

###### 

Inpatient Postoperative Complications for Hip Fracture Patients From 2009 to 2016.

![](10.1177_2151459320929581-table3)

  Parameter (%)                                     2009             2010             2011             2012             2013             2014             2015             2016             *P* value
  ------------------------------------------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- -----------
  Overall complication rate                         173 483 (51.1)   173 759 (51.2)   180 044 (52.0)   172 075 (50.7)   167 440 (48.2)   163 575 (45.7)   150 960 (42.4)   129 105 (38.4)   \<.001
  Overall complication rate excluding transfusion   97 730 (28.8)    97 735 (28.8)    102 145 (29.5)   99 165 (29.2)    98 885 (28.5)    101 080 (28.3)   97 630 (27.4)    89 925 (26.8)    \<.001
  Myocardial infarction                             8130 (2.4)       7662 (2.3)       7438 (2.1)       7340 (2.2)       6685 (1.9)       6180 (1.7)       5950 (1.7)       6100 (1.8)       \<.001
  Cardiac arrest                                    1725 (0.5)       1758 (0.5)       2004 (0.6)       1990 (0.6)       2160 (0.6)       2345 (0.7)       2665 (0.7)       2250 (0.7)       \<.001
  Deep vein thromboses                              3676 (1.1)       4216 (1.2)       4064 (1.2)       3995 (1.2)       3955 (1.1)       4000 (1.1)       4015 (1.1)       3430 (1.0)       \<.001
  Pulmonary emboli                                  2637 (0.8)       2868 (0.8)       2870 (0.8)       2505 (0.7)       2540 (0.7)       2565 (0.7)       2685 (0.7)       2535 (0.7)       \<.001
  Respiratory failures                              8954 (2.6)       10 328 (3.0)     12 692 (3.7)     17 455 (5.1)     17 740 (5.1)     19 020 (5.3)     19 010 (5.3)     17 665 (5.3)     \<.001
  Pneumonia                                         17 977 (5.3)     18 587 (5.5)     18 096 (5.2)     17 890 (5.3)     17 635 (5.1)     17 835 (5.0)     16 590 (4.7)     14 015 (4.2)     \<.001
  Hematoma/seromas                                  4432 (1.3)       3966 (1.2)       4337 (1.3)       3485 (1.0)       3600 (1.0)       3425 (1.0)       3125 (0.9)       2745 (0.8)       \<.001
  Mechanical complications                          3212 (0.9)       2943 (0.9)       3256 (0.9)       3115 (0.9)       3215 (0.9)       3500 (1.0)       3330 (0.9)       3815 (1.1)       \<.001
  Sepsis                                            6093 (1.8)       6559 (1.9)       6407 (1.9)       6870 (2.0)       7505 (2.2)       8600 (2.4)       9365 (2.6)       8810 (2.6)       \<.001
  Urinary tract infections                          60 914 (17.9)    60 105 (17.7)    64 430 (18.6)    59 915 (17.7)    59 105 (17.0)    59 290 (16.6)    56 385 (15.8)    49 540 (14.8)    \<.001
  Transfusions                                      115 292 (33.9)   115 067 (33.9)   119 550 (34.5)   111 695 (32.9)   104 415 (30.1)   95 355 (26.6)    81 085 (22.8)    59 195 (17.6)    \<.001

Diagnoses and Procedures {#section10-2151459320929581}
------------------------

The most common *ICD-9* and *ICD-10* fracture diagnoses were "closed fracture of intertrochanteric section of neck of femur" (n = 863 154) and "displaced intertrochanteric fracture of left femur, initial encounter for closed fracture" (n = 76 365), respectively ([Table 4](#table4-2151459320929581){ref-type="table"}). The most common *ICD-9* and *ICD-10* secondary diagnosis was "acute hemorrhagic anemia" (*ICD-9*: n = 277 656; *ICD-10*: n = 47 540; [Table 5](#table5-2151459320929581){ref-type="table"}). The most common *ICD-9* and *ICD-10* primary procedures performed were "open reduction of fracture with internal fixation, femur" (n = 617 506) and "reposition left upper femur with internal fixation device, open approach" (n = 33 145), respectively ([Table 6](#table6-2151459320929581){ref-type="table"}).

###### 

Primary Diagnosis of Hip Fracture Patients.

![](10.1177_2151459320929581-table4)

  Diagnosis code   Description                                                                                  N (%)
  ---------------- -------------------------------------------------------------------------------------------- ----------------
  *ICD-9*                                                                                                       
   820.21          Closed fracture of intertrochanteric section of neck of femur                                863 154 (31.3)
   820.8           Closed fracture of unspecified part of neck of femur                                         481 625 (17.4)
   820.09          Other closed transcervical fracture of neck of femur                                         410 492 (14.9)
   820.22          Closed fracture of subtrochanteric section of neck of femur                                  109 211 (4.0)
   820.20          Closed fracture of trochanteric section of neck of femur                                     69 616 (2.5)
  *ICD-10*                                                                                                      
   S72.142A        Displaced intertrochanteric fracture of left femur, initial encounter for closed fracture    76 365 (2.8)
   S72.141A        Displaced intertrochanteric fracture of right femur, initial encounter for closed fracture   74 195 (2.7)
   S72.002A        Fracture of unspecified part of neck of left femur, initial encounter for closed fracture    46 045 (1.7)
   S72.001A        Fracture of unspecified part of neck of right femur, initial encounter for closed fracture   43 095 (1.6)
   S72.012A        Unspecified intracapsular fracture of left femur, initial encounter for closed fracture      36 195 (1.3)

Abbreviations: *ICD-9, International Classification of Disease, Ninth Edition; ICD-10, International Classification of Disease, Tenth Edition*; N, number.

###### 

Secondary Diagnosis of Hip Fracture Patients.

![](10.1177_2151459320929581-table5)

  Diagnosis code   Description                                   N (%)
  ---------------- --------------------------------------------- ----------------
  *ICD-9*                                                        
   285.1           Acute posthemorrhagic anemia                  277 656 (10.1)
   599.0           Urinary tract infection, site not specified   139 661 (5.1)
   584.9           Acute kidney failure, unspecified             90 924 (3.3)
   276.1           Hyposmolality and/or hyponatremia             80 555 (2.9)
   401.9           Unspecified essential hypertension            78 908 (2.9)
  *ICD-10*                                                       
   D62             Acute posthemorrhagic anemia                  47,540 (1.7)
   N39.0           Urinary tract infection, site not specified   19 380 (0.7)
   N17.9           Acute kidney failure, unspecified             17 915 (0.6)
   I10             Essential (primary) hypertension              17 540 (0.6)
   E87.1           Hypo-osmolality and hyponatremia              10 930 (0.4)

Abbreviations: *ICD-9, International Classification of Disease, Ninth Edition; ICD-10, International Classification of Disease, Tenth Edition*; N, number.

###### 

Primary Procedure of Hip Fracture Patients.

![](10.1177_2151459320929581-table6)

  Procedure code   Description                                                                                       N (%)
  ---------------- ------------------------------------------------------------------------------------------------- ----------------
  *ICD-9*                                                                                                            
   793.5           Open reduction of fracture with internal fixation, femur                                          617 506 (22.4)
   815.2           Partial hip replacement                                                                           615 255 (22.3)
   791.5           Closed reduction of fracture with internal fixation, femur                                        465 451 (16.9)
   785.5           Internal fixation of bone without fracture reduction, femur                                       162 743 (5.9)
   815.1           Total hip replacement                                                                             93 603 (3.4)
  *ICD-10*                                                                                                           
   0QS.704Z        Reposition left upper femur with internal fixation device, open approach                          33 145 (1.2)
   0QS.604Z        Reposition right upper femur with internal fixation device, open approach                         32 760 (1.2)
   0QS.706Z        Reposition left upper femur with intramedullary internal fixation device, open approach           28 730 (1.0)
   0QS.606Z        Reposition right upper femur with intramedullary internal fixation device, open approach          27 120 (1.0)
   0QS.736Z        Reposition left upper femur with intramedullary internal fixation device, percutaneous approach   17 655 (0.6)

Abbreviations: *ICD-9, International Classification of Disease, Ninth Edition; ICD-10, International Classification of Disease, Tenth Edition*; N, number.

Discussion {#section11-2151459320929581}
==========

Hip fractures continue to pose problems for elderly populations in the form of poor outcomes. The current study utilized the NIS to assess incidence, demographics, postoperative outcomes, and the most common diagnoses and procedures. Hip fracture incidence fluctuated throughout the study but ended up grossly decreasing from 2009 to 2016, which contrasts with previous studies projecting increases in hip fracture incidence in the United States. An increasing number of males, smokers, and obese individuals experienced hip fractures. Additionally, the mortality and overall complication rate of hip fractures decreased. Specifically, rates of MIs, DVTs, and transfusions decreased, while rates of cardiac arrests, mechanical complications, and sepsis increased. The most common primary diagnosis overall was "closed fracture of intertrochanteric section of neck of femur" and the most common primary procedure was "open reduction of fracture with internal fixation, femur." Several trends observed in this study support the notion of improved perioperative management. Although these results cannot be directly linked to any particular intervention, the large number of previous hip fracture studies has likely influenced these trends.

This study is not without limitations. Our data set is highly dependent upon *ICD* diagnoses and procedures, and as the study period contains the transition between *ICD-9* and *ICD-10* coding systems, discrepancies may exist. Furthermore, some procedure codes, such as "open reduction of fracture with internal fixation, femur" are somewhat ambiguous and subject to interpretation based on physician preference. Accordingly, physicians may consider cephalomedullary nail placement open reduction internal fixation whereas another provider may not. Additionally, with the utilization of the NIS database, we were subjected to the inpatient stay only and unable to track patient data post-discharge. Despite these limitations, this study was able to provide valuable inpatient trends regarding hip fracture management.

Low velocity hip fractures are regarded as an osteoporosis-related or fragility fracture, as risk for this type of fracture dramatically increases with each decrease in standard deviation of bone mineral density.^[@bibr23-2151459320929581]^ In the present study, the proportion of individuals sustaining hip fractures with a diagnosis of osteoporosis decreased by a rate of 19.5% from 2009 to 2016 (20.5%-16.5%). This decline may be a reflection of updated screening recommendations from the U.S. Preventive Services Task Force in 2011 pertaining to postmenopausal females.^[@bibr24-2151459320929581]^ However, the group did not provide recommendations for males as there was insufficient evidence demonstrating its efficacy. These recommendations, or lack thereof, may explain the decreasing number of osteoporotic hip fracture patients and increasing number of males sustaining hip fractures. The latter trend should not be taken lightly, as males have demonstrated increased mortality rates at 1 year with comparison to females.^[@bibr25-2151459320929581],[@bibr26-2151459320929581]^ Instead of improved hip fracture screening and prevention as the reason for decreasing osteoporotic fractures, this downward trend may be a representation of worsening osteoporosis detection. In a trend study performed by King and Fiorentino,^[@bibr27-2151459320929581]^ the authors analyzed Medicare claims for dual-energy X-ray absorptiometry (DEXA) scans from 2002 to 2010. The authors noted a downward trend in utilization from 2007 to 2010, attributing the decrease to a 56% reduction in Medicare reimbursement for DEXA scans that occurred from 2006 to 2010. As a result, an estimated 800 000 fewer scans were performed, which would have prevented a projected 12 000 fragility fractures. Furthermore, in a study performed by Amarnath et al,^[@bibr28-2151459320929581]^ the authors investigated osteoporosis screening from 2006 to 2012, concluding that over 40% of women aged 65 to 74 and nearly 60% of women greater than age 75 fail to receive proper osteoporosis screening. Moreover, in an institutional study performed by Antonelli et al,^[@bibr29-2151459320929581]^ the authors examined how frequently patients underwent osteoporosis workup following a hip fracture, determining only 10.3% of patients received proper screening and 19% of patients received treatment for their presumed osteoporosis. These conclusions are noteworthy, as studies have demonstrated a higher than 2-fold increase in risk of subsequent fracture after the initial fragility fracture.^[@bibr30-2151459320929581]^ The shortcomings in the detection of osteoporosis may be the reason fewer individuals diagnosed with osteoporosis are sustaining hip fractures. Therefore, osteoporosis detection may be a focus for improvement to continue decreasing hip fracture incidence.

Over the course of the study, the proportion of hip fracture patients that smoked increased from 9.1% in 2009 to 12.3% in 2016. Although meta-analyses have clearly demonstrated smokers to be at heightened risk of hip fractures, this trend is somewhat surprising, particularly as the proportion of smokers in the United States has been decreasing since 2005.^[@bibr31-2151459320929581][@bibr32-2151459320929581][@bibr33-2151459320929581]-[@bibr34-2151459320929581]^ This trend should not be overlooked, as Solbakken et al^[@bibr35-2151459320929581]^ demonstrated hip fracture patients who smoked have a greater than 3-fold increase in mortality risk. As the 45 to 64 age-group in the United States constitutes the largest proportion of current smokers, the number of smokers sustaining hip fractures may continue to rise as these individuals grow older and the amalgamation of risk increases.^[@bibr9-2151459320929581],[@bibr36-2151459320929581]^ Thus, heightened efforts must be taken to encourage smoking cessation in this age group to minimize not only the risk of fracture but also the risk of mortality.

The current study reported a decreasing mortality rate from 2.9% in 2009 to 2.4% in 2016. Although a number of reports have investigated mortality rates in hip fracture patients, very few have analyzed inpatient mortality in a temporal manner like the present study. In a 2007 HCUP Report,^[@bibr37-2151459320929581]^ inpatient mortality rates of femoral neck fractures were estimated at 2.81%. In a database study, Kiriakopoulos et al^[@bibr38-2151459320929581]^ investigated mortality rates in individuals having intertrochanteric fractures and noted the overall inpatient mortality rate to be 1.7% from 2005 to 2010, with males possessing significantly higher mortality rates than females (2.56% vs 1.39%; *P* \< .0002). It should be noted that these investigations report different mortality rates as they examine patients with different anatomical fractures. Accordingly, studies reporting hip fracture mortality should be perceived with caution as a large number of factors, such as anatomical location, sex, time-to-operation, or the presence of certain comorbidities contribute to the variability seen with this rate.^[@bibr39-2151459320929581],[@bibr40-2151459320929581]^ The present study reports on patients with femoral neck and intertrochanteric fractures, in addition to femoral head and subtrochanteric fractures, and our mortality rates align similarly with the previous reports. As such, the decreasing rate may be a result of improving patient optimization and/or perioperative course.

Beyond patient specific factors, institutions have implemented programs that care specifically for hip fracture patients. One such program that has been investigated, called the "Fracture Liaison Service" (FLS), focuses on providing fracture prevention services, such as osteoporosis workup or education on tobacco use, in order to minimize risk of negative outcomes.^[@bibr41-2151459320929581]^ In a systematic review and meta-analysis performed by Wu et al,^[@bibr42-2151459320929581]^ the authors analyzed 74 studies comparing FLS with the usual standard of care (SOC). The authors noted significant increases in DEXA scans (FLS: 48.0% vs SOC: 23.5%) and subsequent treatment initiation (38.0% vs. 17.2%), as well as decreases in subsequent fractures (6.4% vs 13.4%) and overall mortality (10.4% vs 15.8%) in patients cared for under the FLS. Another similar version, the Ortho-Geriatric Care approach, is comprised of 3 models (routine geriatric consultation, geriatric ward, and shared care models) that involve varying levels of comanagement between orthopedic surgeons and geriatricians.^[@bibr18-2151459320929581][@bibr19-2151459320929581]-[@bibr20-2151459320929581]^ In a systematic review and meta-analysis performed by Grigoryan et al^[@bibr18-2151459320929581]^, the authors analyzed 18 studies comparing Ortho-Geriatric Care models to the usual SOC. The authors noted significant reductions in inpatient (relative risk \[RR\]: 0.60; 95% CI: 0.43-0.84) and long-term mortality (RR: 0.83; 95% CI: 0.74-0.94), while a decrease in mean LOS (−0.25; 95% CI: −0.44 to −0.05) was also observed. Interventions emphasizing better coordination and communication, such as the previously mentioned models, may be the future standard of hip fracture care in the United States, as represented by the decreased mortality and overall complication rates in the present study.

Looking past institutional changes, studies have explored health care payment models and their effects on hip fracture patients. One such approach that has been gaining attention is the bundled payment model. This initiative involves expanding the episode of care up to 90 days posthospital-discharge to improve care quality by increasing the coordination of care between providers.^[@bibr43-2151459320929581]^ In a Taiwanese database study performed by Tung et al,^[@bibr44-2151459320929581]^ the authors investigated bundled payments within the confines of a single-payer health care model and assessed the impact it had on hip fracture patients. After bundled payment implementation in 2010, the authors noted a decrease in all-cause 30-day unplanned readmission rates (14.0%-12.9%) and mean LOS (9.0-8.1 days). However, no decrease was observed with regard to mortality. The health care systems between Taiwan and the United States differ, yet an increasing number of states are adopting bundled payment models in order to reduce cost and improve outcomes. Although the Centers for Medicare and Medicaid has recently withdrawn a program mandating bundled payments for hip fractures, revisions to make the program voluntary, shorten the episode of care, or appropriately define the bundled payments to address unexpected costs may make this model a viable option for hip fractures in the future.

Conclusion {#section12-2151459320929581}
==========

Hip fractures continue to demand a large portion of orthopedic resources in the United States. The present study demonstrated an overall decrease in the number of hip fractures, as well as shorter length of stays. Furthermore, patients experienced a decrease in mortality and overall complication rates. These results contrast with previous studies projecting exponential increases in hip fractures throughout the United States and may be an indication of improving perioperative courses for patients. However, this article also identified several areas in the prevention and management of hip fractures that can be improved to further reduce negative outcomes. As such, future investigations should examine which patient-specific factors pose the greatest risk of postoperative morbidity and mortality, and whether the utilization of programs, such as the FLS, mitigates postoperative risk of these certain populations. This will allow providers to tailor postoperative care specific to patients, thereby increasing the likelihood for successful outcomes following this devastating injury.
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